Novartis Aktie

91.81 CHF -2.59CHF -2.74%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>

Aktionärsstruktur

Inhaber in %
Freefloat 83.87
Novartis AG 10.38
Sandoz Family Foundation 3.53
Novartis Foundation For Employee Participation 2.14
UBS Asset Management Switzerland AG 2.09
Government Pension Fund - Global (the) 2.09
Vanguard Total International Stock Index Fund 1.37
American Funds Europacific Growth Fund 0.79
Vanguard Health Care Fund 0.79
Capital Income Builder 0.77
Csif (ch) Umbrella - Switzerland Total Market Index Blue 0.69
American Funds Capital World Growth & Income Fund 0.59
Vanguard Developed Markets Index Fund 0.53

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2015 2016 2017 2018 2019
Personal am Ende des Jahres 118'700 118'393 121'597 125'161 103'914
Umsatz pro Mitarbeiter in Mio. EUR 0.40 0.40 0.40 0.41 0.45

Bilanz (in Mio. EUR) - Aktiva

2015 2016 2017 2018 2019
Summe Umlaufvermögen 22'868 25'339 27'489 35'058 28'570
Summe Anlagevermögen 99'076 100'247 99'977 109'132 81'944
Summe Aktiva 132'037 132'519 129'833 143'578 114'665

Bilanz (in Mio. EUR) - Passiva

2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 21'953 24'191 27'700 31'634 28'225
Summe Fremdkapital 54'838 56'403 57'498 66'003 60'872
Summe Eigenkapital 77'199 76'115 72'334 77'575 53'793
Summe Passiva 132'037 132'519 129'833 143'578 114'665

Adresse

Lichtstrasse 35, 4056 Basel
Telefon +41 (61) 324-11-11
Fax +41 (61) 324-80-01
Internet http://www.novartis.com

Management

Ameet Mallik
Head-Global Marketing, Value & Access
Andreas von Planta
Independent Non-Executive Director
Ann Marie Fudge
Independent Non-Executive Director
Bertrand Bodson
Chief Digital Officer
Charles L. Sawyers
Independent Non-Executive Director
Charlie Hough
VP & Global Head-Strategy
Charlotte Pamer-Wieser
Secretary
Dan Bar-Zohar
Global Head-Neuroscience Development
David Lebwohl
SVP & Franchise Global Program Head
Elizabeth Theophille
Chief Technology & Digital Officer
Enrico Cipro Vanni
Vice Chairman
Frans van Houten
Independent Non-Executive Director
Hans Jörg Reinhardt
Independent Non-Executive Chairman
Harry Werner Kirsch
Chief Financial Officer
James E. Bradner
President-NIBR
Janneke van der Kamp
Member Executive Committee
Jeffrey Engelman
Vice President & Global Head-Oncology NIBR
John Tsai
Chief Medical Officer
Klaus Moosmayer
Chief Ethics Risk & Compliance Officer
Lilli Petruzzelli
Global Head-Immuno-Oncology
Mark Levick
Global Head
Mark Never
Head-Cluster Western Europe
Mary Elizabeth Doherty
Independent Non-Executive Director
Mimi Huizinga
VP & Head-Strategic Data
Nancy C. Andrews
Independent Non-Executive Director
Natacha Theytaz
Head-Internal Audit
Patrice Bula
Director
Samir Shah
Global Head-Investor Relations
Samit Hirawat
Head- Global Oncology Development
Shannon Thyme Klinger
Group General Counsel
Srikant T. Madhav Datar
Independent Non-Executive Director
Steffen Lang
Global Head-Technical Operations
Stephen Moran
Global Head-Strategy
Steven Baert
Chief People & Organization Officer
Ton Büchner
Independent Non-Executive Director
Vasant Narasimhan
Chief Executive Officer
William Thomas Winters
Independent Non-Executive Director

Eintrag hinzufügen

;